CFHCX Fees and Costs — Catalyst/Millburn Dynamic Commodity Strategy Fund, Class C

Data updated: 2025-02-28

The net expense ratio is 3.01% (4.82% before fee waivers). There are no sales loads or redemption fees. In fiscal 2024 the fund paid $6K in broker commissions, 0.0504% of average net assets, and portfolio turnover was 112%.

CFHCX Fees and Expenses

Annual operating expenses and sales charges of CFHCX. Prospectus, as of October 31, 2024.

Annual operating expenses
Management fee1.75%
12b-1 fee1.00%
Other expenses2.05%
Gross expense ratio4.82%
Fee waiver−1.81%
Net expense ratio3.01%
Sales charges
Max front load0.00%
Max deferred load0.00%
Redemption fee0.00%
Expense limitation in place (N-CEN)Yes
Fees waived or reduced during the yearYes
Waived fees subject to recoupmentYes

CFHCX Costs Over Time

On $10,000 invested in CFHCX, assuming 5% a year before costs, total costs come to $1,837 over 5 years, cutting the return by 3.21% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).

$10,000 investedSell after 1 yearSell after 3 yearsSell after 5 years
Value before costs$10,500$11,576$12,763
Fund expenses (net expense ratio 3.01%)$316$965$1,638
Trading costs (broker commissions)$5$16$27
Lost growth on money paid in costs$0$49$172
Total costs$321$1,031$1,837
Value after costs$10,179$10,546$10,926
Impact on return, per year3.21%3.21%3.21%

CFHCX Trading Costs

Brokerage costs reported on SEC Form N-CEN for the fiscal year ending June 30, 2024.

  • Explicit cost rate (commissions ÷ average net assets): 0.0504%
  • Total broker commissions: $6K
  • Bought from dealers (principal trades, not a cost): $4.0M
  • Portfolio turnover (prospectus): 112%
  • Securities lending: none during the year

CFHCX Agency Brokers

Commissions paid.

BrokerAmountShare
GOLDMAN SACHS$6K100.00%

CFHCX Dealer Counterparties

Securities bought directly from dealers (principal trades).

BrokerAmountShare
US BANCORP$4.0M100.00%
GOLDMAN SACHS$110.00%

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.